Magnesium bei Nervenschmerzen und Polyneuropathie

Hier erhalten Sie eine Liste an Quellen zum Thema Magnesium und Polyneuropathie bzw. Nervenschädigungen. Diese Liste war Grundlage des 👉 Blogbeitrages "Magnesium bei Polyneuropathie"

Grundlagen zu Polyneuropathie

Baron R., Binder A., Wasner G.
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.
The Lancet Neurology, 2010.

Berlit P.
Polyneuropathien – Klinik, Diagnostik und Therapie.
Deutsches Ärzteblatt, 2014.

Magnesium und Nervensystem

de Baaij J.H.F., Hoenderop J.G.J., Bindels R.J.M.
Magnesium in man: implications for health and disease.
Physiological Reviews, 2015.

Vink R., Nechifor M.
Magnesium in the Central Nervous System.
University of Adelaide Press, 2011.

Romani A.M.P.
Magnesium homeostasis in health and disease.
Metal Ions in Life Sciences, 2013.

Magnesium bei Schmerzen & neuromuskulären Beschwerden

Begon S. et al.
Magnesium and pain.
Nutrients, 2018.

Pickering G., Morel V., Simen E.
Oral magnesium treatment in patients with neuropathic pain.
Magnes Research, 2011.

Garrison S.R. et al.
Magnesium for skeletal muscle cramps.
Cochrane Database of Systematic Reviews, 2020.

Magnesium bei Polyneuropathie – wissenschaftlicher Hintergrund

Passende Quellen:

Pickering G. et al.Oral magnesium treatment in neuropathic pain

Begon S. et al. Magnesium and pain (Nutrients)

Vink R., Nechifor M. – (Kapitel zu NMDA-Rezeptoren)


Magnesium bei Diabetes & diabetischer Polyneuropathie

Sales C.H., Pedrosa L.F.C.
Magnesium and diabetes mellitus: their relation.
Clinical Nutrition, 2006.

Hruby A. et al.
Magnesium intake and risk of type 2 diabetes.
Diabetes Care, 2014.

Bioverfügbarkeit & Magnesiumverbindungen

Ranade V.V., Somberg J.C.
Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts.
American Journal of Therapeutics, 2001.

Coudray C. et al.
Bioavailability of different magnesium salts.
European Journal of Clinical Nutrition, 2005.


PEA (Palmitoylethanolamid) und neuropathische Schmerzen

Keppel Hesselink J.M.
Palmitoylethanolamide: a natural body-own anti-inflammatory.
Journal of Pain Research, 2013.

Schifilliti C. et al.
Palmitoylethanolamide in neuropathic pain.
CNS & Neurological Disorders – Drug Targets, 2014.

Andrieu K. et al.
PEA for chronic pain: a meta-analysis.
Pain Physician, 2019.


Fettsäuren & Nervengesundheit

Calder P.C.
Omega-3 fatty acids and inflammatory processes.
Nutrients, 2010.

Dyall S.C.
Long-chain omega-3 fatty acids and the brain.
Nutrients, 2015.

Zhang Y. et al.
Omega-3 fatty acids in peripheral neuropathy.
Journal of Neuroinflammation, 2018.


Ergänzende Fachquellen (Patienten & Praxis)

Deutsche Gesellschaft für Neurologie (DGN)
Leitlinien: Polyneuropathien

European Federation of Neurological Societies (EFNS)
Guidelines on the management of neuropathic pain

National Institutes of Health (NIH)
Magnesium – Fact Sheet for Health Professionals